Vogt-Koyanagi-Harada disease associated with interferon alpha-2b/ribavirin combination therapy
- 1 November 2003
- journal article
- case report
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 10 (6) , 467-470
- https://doi.org/10.1046/j.1365-2893.2003.00456.x
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Mechanism of action of ribavirin in the combination treatment of chronic HCV infectionHepatology, 2002
- Recent Advancements in the Treatment of Chronic Myelogenous LeukemiaAnnual Review of Medicine, 2002
- Lupus syndrome, hypothyroidism and bullous skin lesions after interferon alfa therapy for hepatitis C in a haemodialysis patientNephrology Dialysis Transplantation, 2002
- Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell CancerNew England Journal of Medicine, 2001
- Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus ErythematosusScience, 2001
- Hairy cell leukemiaCurrent Treatment Options in Oncology, 2001
- Current Treatment Strategies for Chronic Hepatitis B and CAnnual Review of Medicine, 2001
- Autoimmunity induced by interferon-α therapy for chronic viral hepatitisBiomedicine & Pharmacotherapy, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Sarcoidosis associated with interferon-α therapy for chronic hepatitis CJournal of Hepatology, 1998